Session Id: nsk5mg64 (Pls: 4fec6d29-1023-419e-828b-88115b700e90) Aaron Ashby returns from injury and outlines the pitching plan designed to ease him back in 5:09 Now PlayingPausedAd Playing ...

Friedreich Ataxia (FA)Design has developed a new drug product, DT-216P2, for patients with FA that demonstrates an improved pharmacokinetic (PK) profile and a favorable injection site safety ...

In a major step toward securing global food supplies and advancing sustainable agriculture, a team of scientists has proposed ...

The Company will also outline the design of its first-in-human study, ELIMINATE-B, in patients with chronic hepatitis B. Company management will present these updates and host panel discussions on ...